{"id":"https://openalex.org/W2000212898","doi":"https://doi.org/10.1158/1535-7163.targ-09-c200","title":"Abstract C200: Effects of indirubin derivatives on the FLT3 activity and growth of acute myeloid leukemia cell lines","display_name":"Abstract C200: Effects of indirubin derivatives on the FLT3 activity and growth of acute myeloid leukemia cell lines","publication_year":2009,"publication_date":"2009-12-01","ids":{"openalex":"https://openalex.org/W2000212898","doi":"https://doi.org/10.1158/1535-7163.targ-09-c200","mag":"2000212898"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-09-c200","doi":"https://doi.org/10.1158/1535-7163.targ-09-c200","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-c200","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109919430","display_name":"Sang\u2010Un Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151417","display_name":"Korea Research Institute of Chemical Technology","ror":"https://ror.org/043k4kk20","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4210151417"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sang-Un Choi","raw_affiliation_strings":["1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;","institution_ids":["https://openalex.org/I4210151417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014699929","display_name":"Jin Hee Ahn","orcid":"https://orcid.org/0000-0002-6957-6062","observed_orcids":["https://orcid.org/0000-0002-6957-6062"]},"institutions":[{"id":"https://openalex.org/I4210151417","display_name":"Korea Research Institute of Chemical Technology","ror":"https://ror.org/043k4kk20","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4210151417"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jin Hee Ahn","raw_affiliation_strings":["1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;","institution_ids":["https://openalex.org/I4210151417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112551396","display_name":"Min\u2010Jin Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151417","display_name":"Korea Research Institute of Chemical Technology","ror":"https://ror.org/043k4kk20","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4210151417"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Min-Jin Kim","raw_affiliation_strings":["1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;","institution_ids":["https://openalex.org/I4210151417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003302497","display_name":"Miyoun Yoo","orcid":"https://orcid.org/0000-0001-5516-1512","observed_orcids":["https://orcid.org/0000-0001-5516-1512"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Miyoun Yoo","raw_affiliation_strings":["2 Yonsei University, Seoul, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Yonsei University, Seoul, Republic of Korea;","institution_ids":["https://openalex.org/I193775966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082641550","display_name":"Eunbin Kim","orcid":"https://orcid.org/0000-0002-1608-1402","observed_orcids":["https://orcid.org/0000-0002-1608-1402"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Eunbin Kim","raw_affiliation_strings":["2 Yonsei University, Seoul, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Yonsei University, Seoul, Republic of Korea;","institution_ids":["https://openalex.org/I193775966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054485894","display_name":"Young\u2010Kyoon Kim","orcid":"https://orcid.org/0000-0002-7114-7814","observed_orcids":["https://orcid.org/0000-0002-7114-7814"]},"institutions":[{"id":"https://openalex.org/I110273157","display_name":"Kookmin University","ror":"https://ror.org/0049erg63","country_code":"KR","type":"education","lineage":["https://openalex.org/I110273157"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Young-Kyoon Kim","raw_affiliation_strings":["3 Kookmin University, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3 Kookmin University, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I110273157"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109982184","display_name":"Shi Yong Ryu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151417","display_name":"Korea Research Institute of Chemical Technology","ror":"https://ror.org/043k4kk20","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4210151417"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Shi Yong Ryu","raw_affiliation_strings":["1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;","institution_ids":["https://openalex.org/I4210151417"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054648435","display_name":"Sun\u2010Young Han","orcid":"https://orcid.org/0000-0002-7176-4193","observed_orcids":["https://orcid.org/0000-0002-7176-4193"]},"institutions":[{"id":"https://openalex.org/I4210151417","display_name":"Korea Research Institute of Chemical Technology","ror":"https://ror.org/043k4kk20","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4210151417"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sun-Young Han","raw_affiliation_strings":["1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea;","institution_ids":["https://openalex.org/I4210151417"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"12_Supplement","first_page":"C200","last_page":"C200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indirubin-derivatives","display_name":"indirubin derivatives","score":0.9599999785423279},{"id":"https://openalex.org/keywords/flt3-inhibition","display_name":"FLT3 inhibition","score":0.7839999794960022},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/6-bromoindirubin-3-oxime","display_name":"6-bromoindirubin-3'-oxime","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mv4-11-cells","display_name":"MV4-11 cells","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.8360000252723694},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.9120000004768372},{"id":"https://openalex.org/keywords/antileukemic-agents","display_name":"antileukemic agents","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C2779584974","wikidata":"https://www.wikidata.org/wiki/Q1661452","display_name":"Indirubin","level":3,"score":0.9559049606323242},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7168187499046326},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.5711091160774231},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5196046233177185},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5116760730743408},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5115664601325989},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.44527724385261536},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.44422993063926697},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4409262239933014},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4273309111595154},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41179123520851135},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3398618698120117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25993824005126953},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25643301010131836},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2511916160583496},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22564265131950378},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20928955078125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16937890648841858},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10254204273223877},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C153349607","wikidata":"https://www.wikidata.org/wiki/Q36649","display_name":"Visual arts","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C142316359","wikidata":"https://www.wikidata.org/wiki/Q5967009","display_name":"Indigo","level":2,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-09-c200","doi":"https://doi.org/10.1158/1535-7163.targ-09-c200","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-09-c200","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2073164969","https://openalex.org/W2000771161","https://openalex.org/W2052116382","https://openalex.org/W1993966016","https://openalex.org/W3009629639","https://openalex.org/W2474908407","https://openalex.org/W2772644783","https://openalex.org/W2107759345","https://openalex.org/W4414826347","https://openalex.org/W4379162623"],"abstract_inverted_index":{"Abstract":[0],"Indirubin":[1],"is":[2],"an":[3],"active":[4],"constituent":[5],"of":[6,14,23,50,77,92,108,113,136,153,187],"traditional":[7],"Chinese":[8],"recipe":[9],"used":[10],"for":[11,194],"the":[12,75,106,121,144,150,185],"treatment":[13],"chronic":[15],"myelocytic":[16],"leukemia.":[17],"In":[18,143],"this":[19],"study,":[20],"inhibitory":[21,41,47,66],"activity":[22,42,67],"indirubin":[24,58],"and":[25,37,53,59,94,102,116,139,159,169,173],"its":[26],"derivatives":[27,186],"toward":[28],"Fms-like":[29],"tyrosine":[30],"kinase":[31],"3":[32],"(FLT3)":[33],"was":[34],"examined.":[35],"Indirubin-3\u2032-oxime(IO)":[36],"6-bromoindirubin-3\u2032-oxime(BIO)":[38],"showed":[39],"potent":[40],"against":[43,80],"FLT3":[44,65,93],"with":[45,97,111,133],"50%":[46,170],"concentration":[48],"(IC50)":[49],"79":[51],"nM":[52,115,138],"254":[54],"nM,":[55,118,141],"respectively.":[56,119,142,179],"Meanwhile,":[57],"6-bromoindirubin":[60],"exhibited":[61],"negligible":[62],"effect":[63],"on":[64],"up":[68],"to":[69,130,191],"10":[70],"\u00b5M.":[71],"We":[72],"also":[73],"tested":[74],"cytotoxicity":[76],"those":[78,131],"compounds":[79,132],"acute":[81],"myeloid":[82],"leukemia":[83],"cell":[84,145,151,162],"lines;":[85],"MV4;11":[86,109,154],"cells":[87,96,110,125,155],"harboring":[88],"constitutively":[89],"activated":[90],"form":[91],"RS4;11":[95,124],"wild":[98],"type":[99],"FLT3.":[100],"IO":[101,148,188],"BIO":[103],"potently":[104],"inhibited":[105],"growth":[107],"IC50":[112,134],"30":[114],"61":[117],"On":[120],"other":[122],"hand,":[123],"were":[126],"far":[127],"less":[128],"sensitive":[129],"values":[135],"3600":[137],"820":[140],"cycle":[146,152],"assay,":[147],"arrested":[149],"at":[156,164,171],"G1":[157],"phase,":[158],"increased":[160],"dead":[161],"population":[163],"sub-G1":[165],"phase":[166],"about":[167],"25":[168],"0.1":[172],"1.0":[174],"\u00b5M":[175],"after":[176],"48":[177],"hours,":[178],"These":[180],"results":[181],"strongly":[182],"suggest":[183],"that":[184],"have":[189],"potentials":[190],"be":[192],"developed":[193],"novel":[195],"anti-leukemic":[196],"agents.":[197],"Citation":[198],"Information:":[199],"Mol":[200],"Cancer":[201],"Ther":[202],"2009;8(12":[203],"Suppl):C200.":[204]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}